Incendia Therapeutics, Inc.
- Biotech or pharma, therapeutic R&D
Incendia is a clinical stage company targeting the tumor microenvironment. Our most advanced program is preparing to enter Ph2 trial in 2026. The Company is also advancing a diverse pipeline of currently pre-clinical programs targeting harmful stromal biology.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}